J. Neurol. Neurosurg. Psychiat., 1963, 26,479
The relationship between
enzyme
activity
and
neuroglia
in
the
prodromal
and
demyelinating
stages
of
cyanide
encephalopathy
in
the
rat
M. Z. M. IBRAHIM, PHILANDER B. BRISCOE, JR1.,
OLGA B. BAYLISS, AND C. W. M. ADAMS
From the Department of Pathology. Guy's HospitalMedicalSchool,London
In aprevious communication(IbrahimandAdams, 1963), we suggested that the increased enzymatic activity at the edge of the old yet active plaque of multiple sclerosis was due to the increase in oligo-dendrocyte population in this zone. Our obser-vations on the multiple sclerosis plaque gave no indication whether this increase in neuroglial population and enzyme activity was a primary or secondary event in the demyelinating lesion. For this reason we have studied the neuroglial and enzyme changes in the prodromal stage of the
experimental demyelinating diseaseproduced bythe injection of cyanide into therat.
MATERIAL AND METHODS
Inapilot experiment carried out by the second author, large doses of cyanide were injected intraperitoneally into rats for periods up to five days: repeated daily injectionsweregiven and the maximumdosageachieved in thefour-dayperiodwas105 mg.Althoughno demyeli-natinglesions wereproduced by this regime, the oligo-dendroglia of the corpus callosum showedconsiderably increased oxidative enzyme activity as seen in histo-chemical enzymepreparations (seebelow).Theverylarge dosesofcyanide administered tothe ratsresulted inan
impractically highmortality rate, so the following pro-cedure, modified from Lumsden(1950),wasused instead. Twelve female rats with an average body weight of 275 g.and 13maleratswithanaverageweightof350g. were injected on five days a week with cyanide by the subcutaneous route. Solutions wereprepared tocontain 4 to 8 mg. NaCN per ml. indistilled water. Theinitial dosewas2 to3mg.(0-8 mg./lOOg.bodyweight).This level ofdosagewasmaintaineduntilno animal diedfollowing injection; the nextday the survivors received an incre-mentof0 5to 1mg.intheircyanidedosage.Theabsence of injections on Saturday and Sunday led to increased cyanide sensitivity on Monday, so onthe latter daythe dosagewasreducedby 10mg. Injectionswerecontinued for threeweeks and, bythistime,themaximum dosage of cyanide was 6 0 mg. daily. All animals either died
'Present address: Johns Hopkins Hospital School of Medicine,
Baltimore,Md.,U.S.A.
withintwohoursofinjection or werekilled by chloroform anaesthesia. Five animals survived the three-week period ofinjections and werekilled at intervals from 25 to 92 days from the beginning of the experiment. Within 20 min. of death selected blocks from the brain were eitherplacedin 15%formol-2%ammoniumbromide or werefrozen ontoacryostat chuck in a Slee chuck freezer. Three to four transverse blocks, 2to 3 mm. thick, were usually prepared from each brain. Examination of control material established that autolytic and post-mortem changes had not occurred in the neuroglia during the 20-min. interval between death andfixation.
CYTOLOGICAL METHODS The upper andlower blocks of each brainwere fixed in formol-ammonium bromide at room temperaturefor 24to36 hours and were transferred tofreshfixativeat50°C. for 10min.before sectioning on thefreezing microtomeat20 to
251,.
These sections were then stained by Hortega's methods for oligodendroglia (1956a, republished) and microglia (1954, republished). Penfield's (1924) method was found especially valuable for staining oligodendroglia in the corpus callosum, where these cells are sometimes difficult to impregnate. Cajal's (1913;1916)gold-sublimatemethod and his(1920) modification ofBielschowsky's (1904; 1909) silver method were used todemonstrate astroglia, and the unmodified Bielschowsky methodwasusedfor staining neurones and axones.Somesections from these blocks were stained by Sudan black and by the osmium tetroxide-a-naphthy-lamine(O.T.A.N.) method (Adams, 1959) for triglyceride fats,cholesterol esters, and phospholipids.HISTOCHEMICAL METHODS The middle block of each brain was usually used for enzyme histochemistry. Un-fixed sections were cuton the Slee cryostat at6a. These sections were stained by adenosine triphosphatase2 (PadykulaandHerman,1955a and b), diphosphopyridine nucleotide (DPNH2) tetrazolium reductase3, and lactic dehydrogenase4 methods. The dehydrogenase and re-ductase methods were slight modifications (Adams, Davison, and Gregson, 1963) of the methods of Nachlas, Walker, and Seligman (1958a and b), Hess and Pearse 2ATP phosphohydrolase (3.6.1.4).
3NADH,-tetrazolium reductase = DPN diaphorase = NADH,:
cytochrome oxidoreductase(1.6.2.3).
'L-lactate NADoxidoreductase(11.1.27).
479
Protected by copyright.
on July 4, 2021 by guest.
ESSENTIAL CHARACTERISTICS OF CYANIDE LESIONS
During the first few days of cyanide injectionssome animals develop necrotic lesions, usually seen in the corpus callosum, corpusstriatum, posterior part of the cerebral cortex, hippocampus, medulla, and basal ganglia. These necrotic lesions are character-ized by the relative absenceof cellularreaction in the early stages of their development, by generalized
softening,loss of neuroglialcytoplasmand processes, lossof neurones, pyknotic nuclei (Fig. 1), and early lossof axones (Fig. 2)throughoutthe lesion.
Demyelinating lesionsusually appear from about thefourteenthday of injection onwardsin thecorpus callosum, and, sometimes, also in the callosal radiation, anterior commissure, optic chiasm and tract, hippocampal commissure, fimbria, thalamus,
hypothalamus, substantia nigra, corpus striatum,
hippocampus, cerebellum, medulla, and cerebral cortex.Thesedemyelinatinglesionsarecharacterized by early oligodendroglial proliferation (Fig. 3),
*:;WiaAEs:. ;
FIG. 3
FIG. 1. Necroticlesionincorpusstriatum. Note necrotic centre containingfew cells andperiphery showing
neuro-glialreaction.Hortega'ssilver methodfor microglia x 47. FIG.2. Degenerating axons(cluband granularforms)in lighter-staining necrotic lesion (arrow). Bielschowsky's silvermethodforaxons x 470.
FIG.3. Early demyelinating lesion in corpus callosum. Note density of oligodendroglia in centre of lesion. Hortega's silvcr methodfor oligodendroglia x 118.
FIG. I
Protected by copyright.
on July 4, 2021 by guest.
Enzyme activity andneuroglia intheprodromalanddemyelinating stages of cyanideencephalopathy 481 ..,.,.. ..,. g.'-'": . 5 FIG. S FIG. 4
FIG. 4. More advanceddemyelinatinglesions in corpus callosum (toparrow)and hippocampalcommissure(lower arrow). The dark area between the two is less affected white matter. Hortega's silver method for oligodendroglia x 47. FIG. 5. Partial preservation of axons in a demyelinating lesion of corpus callosum (white arrow). The rounded cells (black arrow) with darknuclei surrounded by pale haloes are gitter cells. Bielschowsky's silver method for axons x 470. followed by demyelination (Fig. 4) but withrelative
preservation ofaxones in the early stages (Fig. 5). The subsequent fate of these lesions is described below.
OLIGODENDROGLIA Ourmaininterestwastoobserve
changes in the oligodendroglia of white matter before the onsetof demyelinating lesions. Forthis purpose, enzymatically active oligodendrocytes were countedin atransversestrip across thecorpus callosum as far as the callosal radiations and in a further strip, atright angles to the first, across the
junction between the corpus callosum and callosal radiation. In enzyme preparations the oligodendro-cyte is recognized by its round, carmalum-stained nucleus and the crescentic or sometimes circular arrangement of enzymatically-active mitochondria around the nucleus (Adams, 1962; Friede, 1962; Yonezawa, Bornstein, Peterson, and Murray, 1962; Ibrahim and Adams, 1963).
The result of these counts is shown in Table I and they show some increase in the number of enzymatically-active oligodendrocytes in the corpus callosum during theprogress ofcyanide encephalo-pathy, even before demyelinating lesions appear. Furthermore, not only did the number of active cells increase, but the intensity ofstaining and size oftheir mitochondria also increased(Fig. 6). Like-wise, the number of enzymatically-active
mito-chondria in theneuropil,which have beententatively identified as those ofoligodendroglia (Ibrahim and Adams, 1963), also show a considerable increase (Fig. 6). The number of enzymatically-active cells increases still further in the early demyelinating lesion (Fig. 7) but, subsequently, the number of active cells declines. These increases in enzymatic activity are not seen in necrotic lesions (Table 1).
TABLE I
NUMBER OF ENZYMATICALLY-ACTIVE OLIGODENDROGLIA IN CORPUS CALLOSUM OF CYANIDE-INJECTED RATS'
Daysof CorpusCallosum
Cvanide
Injection Normal Necrotic Demyelinating
0(control) I 2 3 4 7 10 14 16 25 32 44 56 92 A reas 90, 89, 76, 76 55, 1122 90,105 91,87 1033, 86 178 151 1333 1192 892 Lesions Lesions 30 -86 -- 271, 179 - 302 - 151 - 29 - 121
'Numberof cellsstained forlacticdehydrogenaseper 0.1 sq.mm.
2=necroticlesion elsewhere inbrain
3 =demyelinatinglesion elsewhere inbrain
Protected by copyright.
on July 4, 2021 by guest.
ru
FIG. 6a N4 FIG. 6b Nitro-BT x 470. FIG. 7. Marked increase inlacticde-hydrogenase activity ofoligodengroglia andofbackgroundin earlydemyelinating lesion(arrow) of corpuscallosum. Nitro-BT x 470. FIG. 7 TABLE NUMBER OF OLIGODENDROGLIA IN SILVER-STAINED PREPARATIONS OF CORPUS CALLOSUM
IN CYANIDE-INJECTED RATS
Daysof CyanideInjection No. ofOtigodendroglia per 0-1 sq.mm.
0(control
3
16 Normalarea
Demyelinatinglesion
'Standarderrorofmean
169 ±9-81
237 ±8-3 275 ±9-0
About490
To assess whether this increase in
ezymatically-active cellswasduetoan actualincrease in the num-ber of
oligodendroglia
or dueonly
to a greaterproportion
of cellsbecoming enzymatically-active,
counts were made on the corpus callosum of two animalsafter three and 16
days
ofcyanide
injections(Table II).
Thethree-day animal,
which had noapparentlesion
anywhere
inthebrain,
showsaslight
increase inoligodendroglia
while the16-day animal,
which had an
early demyelinating
lesion in anotherpartof thecorpus
callosum,
showsafurther increase of these cells in normal areas. Inthedemyelinating
lesion in thecorpus callosum of this
16-day
animal the number ofoligodendroglia
isstrikingly
increased eventhough
theresult isprobably
an underestimateon account of
overlapping
ofcells. In silver-stained sections of latedemyelinating
lesions the number ofoligodendrocytes
declines butthey
do notdisappear
completely (Table
I).
In Table III is shown the averageof themean of maximum and minimumdiameters for20
randomly
selected
oligodendroglia
in normal areas of corpus TABLE IIIMEAN DIAMETER OF OLIGODENDROGLIA IN SILVER-STAINED PREPARATIONS OF NORMAL AREAS OF
CORPUS CALLOSUM IN CYANIDE-INJECTED RATS
Daysof Cyanide Injection Mean Diameter of Oligodendroglial
0(control) 34-2±1-6'
3 43-2±5-0
16 56-2 ±5-3
'Mean of maximum and minimumdiameteraofperikaryon
'Standarderrorofmean
Protected by copyright.
on July 4, 2021 by guest.
Enzymeactivity andneurogliainthe prodromaland
demyelinating
stagesof
cyanide
encephalopathy
4831-1v1. S FIG.9
FIG. 8. Acute swelling (arrow) ofoligodendroglia in early demyelinating lesion of cerebral cortex. Hortega's silver methodforoligodendroglia x 470.
FIG. 9. Marchi-positivereaction in gitter cells of latedemyelinating lesion in corpus callosum. O.T.A.N.method x 118.
callosumincontrol, three-day, and 16-dayanimals.
(Oligodendroglial
diameters in the demyelinating lesionof the 16-day animal could not be accuratelymeasured.)These results show that the
oligodendro-glia undergohypertrophy, aswell ashyperplasia (see
above), in the pre-demyelinating phase of cyanide
encephalopathy. Apartfromhyperplasiaand
hyper-trophy, the oligodendroglia in silver-stained
pre-parations of the early demyelinating lesion show that form ofintracellular oedema which is known
asacuteswelling (Fig. 8).
MICROGLIA These cells do not show cytological evidence of activation in silver preparations (see
Ibrahim andAdams, 1963) until adefinite necrotic or advanced demyelinating lesion develops. Gitter cells, containing sudanophilic and Marchi-positive
(O.T.A.N.-black)
granules, appear early in necroticlesions but they are seen only in the later stages of
demyelinating
lesions (Fig. 9). An important differ-ence between these two types of lesion is that the activated and gitter forms of microglia are found in the edge of the early necrotic lesion but, in thedemyelinating lesion, they appear throughout the
plaque, including its edge. Inhistochemicalenzyme preparations, gitter cells show their usual character-istic oxidative activity (see Rubinstein and Smith, 1962; Smith and Rubinstein, 1962; Ibrahim and Adams, 1963).
ASTROCYTES Insilverpreparationsofearlynecrotic
lesions,
hypertrophic and multinucleate forms of astrocytes are seen; activation of these cells leads ontotheformation ofa glioticwalland, finally, toglial
'scarring'.Silverpreparations of earlydemyeli-natinglesionsnevershow much evidence of
astroglial
activation,
but hypertrophicand clasmatodendritic'forms of astrocytes arepresent in theedgeofolder
demyelinating
lesions (Fig. 10). Gliosis and scarformation
(Figs.
11 and12)
areseenin the laststage
of these self-limiting, cyanide-induced,
demyeli-nating lesions. Transformation of protoplasmic
astrocytes into fibrous types is evident in lesions
occurringingreymatter.Increased oxidative enzyme
activity
is seen in activated forms ofastrocytes in both necrotic anddemyelinating lesions(seeFriede,
1962;
Osterbergand Wattenberg, 1962;Rubinstein,
Klatzo,
and Miquel, 1962; Smith andRubinstein,
1962).
SERUM BICARBONATE A small additional group of four animals was injected with a single dose of
cyanide to assess the extent of changes in serum bicarbonate duetothedrug.There wasasubstantial fall in the bicarbonate level (see Table IV) which
was
probably
aresult ofdepressed
tissuerespiration.
'Swelling and fragmentation of astroglial processes together with
cytoplasmicgranularity.
Protected by copyright.
on July 4, 2021 by guest.
lesion in corpus callosum. Cajal'sgold-sublimate method
for
astroglia
x 47.FIG. 12. Higher powerfield of similar lesions to those seen inFig. 11 toshowastroglialfibres x 118.
FIG. 10
FI.G. 11-W ..
FIG. II1 FIG. 12
TABLE IV
CHANGES IN SERUM BICARBONATE
LEVEL AFTER INJECTION OF A SINGLE DOSE OF
CYANIDE IN THE RAT
HoursafterInjectionof2mg.NaCN SerumBicarbonate Level(mM)
0 (control) 1 2 4 24 22-5 5-5 8-5 10-5 20-5 DISCUSSION
CYTOLOGICAL AND ENZYMATIC FEATURESOFCYANIDE
LESIONS Our observations have shown that both necrotic and demyelinatinglesions occur duringthe course ofcyanide encephalopathy in the rat. The necrotic lesion results in complete loss of structure, while the demyelinating lesion is characterized by loss ofmyelin but partialpreservation ofaxons. In
Protected by copyright.
on July 4, 2021 by guest.
Enzyme activity and neuroglia in theprodromal and demyelinating stagesofcyanide encephalopathy 485 the edge of the necrotic lesion, there is a moderate
proliferation of microglia and astrocytes but the oligodendrocyte is not the predominant cell. Before the onsetof demyelination,oligodendrogliaofwhite matterproliferate, undergohypertrophy, and become enzymatically more active; these changes become moreprominent throughout the established demyeli-nating plaque. Proliferation and activation of microglia and astrocytes appear to be a secondary response to demyelination, as these changes follow but do not precede formation of the plaque.
These observations indicate that increased meta-bolic activity of oligodendroglia is a feature of the prodromal stage of cyanide demyelination. The initial increase in enzyme activity of the oligoden-droglia does not appear to be due simply to increased activity in a greater proportion of these cells, for the'silver' counts and cellular dimensions show com-parable increasestothose in the 'enzyme' counts (see Tables I, IL, Ill). It is apparent, therefore, that the increased enzyme activity of the oligodendroglia is dueto both hyperplasia and hypertrophy of these cells. It should be noted, however, that we have assumed that the initial increase in the number of oligodendroglia is due to hyperplasia (see Lewis and Swank, 1953; Smart, 1960; Koenig, 1960; Smart and Leblond, 1961; Adrian and Walker, 1962; Koenig, Bunge, and Bunge, 1962) but the possibility that it is due to infiltration or migration of these cells has not been entirely excluded.
Although the oligodendroglia proliferate and become enzymatically active in the early demyeli-nating lesion (the stage associated with myelin pallor) their numbers and enzyme activity subsequently decline during the later Marchi-positive and gliotic stagesof the plaque. We are uncertain whether this subsequent fall in oligodendroglial population and enzymeactivity indicates that cyanide demyelination is a non-progressive and self-limiting lesion or whether it is that the withdrawal of cyanide allows thedemyelinating process to halt.
Previous studies have indicated that both necrotic and demyelinating lesions result from prolonged administration of cyanidetoanimals(Ferraro, 1933; Hurst, 1942; 1944; 1952; Lumsden, 1950; Levine and Stypulkowski, 1959) but a recent report has described lesions after brief exposure of animals to high concentrations of cyanide (van Houten and Friede,1961).From ourpilot studiesitwould appear that the latter technique produces predominantly necrotic and not demyelinating lesions. Necrotic lesions,whetherproduced byischaemia(Macdonald and Spector, 1963), freezing (Rubinstein, Klatzo, and Miquel, 1962), or by cyanide result in little
oligodendroglial proliferation and little increase in oxidative enzymeactivityattheedge of the softened
area. This circumstance may explain van Houten
and Friede's observation of increased oxidative enzyme activity in astrocytes, which are
character-istically seen at theedge of necrotic lesions andnot in theoligodendroglia of theircyanide-injected rats. These authors, however, noteda diffuse increase in the enzymaticstaining of white matter, which
prob-ably corresponds to the increased mitochondrial
activityobservedbyusinwhitematter.
MECHANISM OF CYANIDEDEMYELINATION Itis known thatcyanide is notacumulative poison(Hurst, 1940; Wyndham,1941)and it isnottheproductsofcyanide
metabolism that cause cyanide encephalopathy (Rose, Harris, and Chen, 1954). Van Houten and Friede(1961)andothers haveattributedthe
encepha-lopathy to the inhibition of cytochrome oxidase by cyanide but, if this explanation isaccepted, itis
difficulttoexplain the absence of lesions in the many other organs that depend upon oxidative meta-bolism. Moreover, cyanide inhibits a wide range of metal-dependant enzymes and it is, therefore, difficult to accept that cytochrome oxidase is the only enzyme to beimpaired by thispoison.
Gallagher, Judah, and Rees (1956) found that cyanideimpairs thecondensationofacetylcoenzyme A withoa-glycerophosphate, resulting in diminished
products ofphosphatidicacid,ametabolicprecursor of the phospholipids. However, failure of
phos-pholipid synthesis in brain would not necessarily
promote demyelination, for it has been shown that myelin phospholipids are metabolically rather inert and have, at most, only a slow turnover
(Davison
andDobbing, 1960).
It is tempting to speculate that cyanide damages
either vascular endothelium or the
oligodendrocyte
and that this results in local oedema of white matter (see Levine, 1960; Luse, 1960; van Houten and Friede, 1961). Such oedema has been observed in cyanide encephalopathy in the form of myelin pallor or reticulation and may itself, for reasons
unknown, cause demyelination
(Lumsden
and Pomerat, 1951;Lumsden, 1957; Bunge, Bunge, and Ris, 1960;vanHoutenandFriede, 1961).The oligo-dendroglial changes we have observed incyanide
encephalopathycould be
explained
ashyperactivity
of these cells in response to oedema. In this con-nexion the oligodendrocyte has beenregarded
as an osmo-regulator between the blood vessel and brain (Lumsden, 1957; Katzman,1961).
RELATIONSHIP OF CYANIDE DEMYELINATION TO MUL-TIPLE
SCLEROSIS
The main purpose of thisexperi-mental study has been to establish whether the increased
oligodendroglial
population
and enzymeactivity in the multiple sclerosis
plaque
(Ibrahim
Protected by copyright.
on July 4, 2021 by guest.
fore,essentially thesameinbothconditions butthe
subsequentprogress ofthelesions is often different.
SUMMARY
After a few days of cyanide injections, rats
com-monly develop necrotic lesions in the brain but, aftertwo weeks ofinjections, demyelinating lesions appear-predominantly in the corpus callosum. In theprodromal stages, before the onset of demyeli-nation, theoligodendroglia of the corpus callosum show increasedenzyme activity and undergo
hyper-plasia andhypertrophy. These changesbecomemore
marked in the early demyelinating lesion but they
regress asthe lesion maturesand becomes inactive.
The neuroglial reaction around necrotic lesions is predominantly astrocytic and microglial while the oligodendroglial element, described above, is not prominent.
Itissuggested that thehyperactivity of the oligo-dendroglia in the prodromal stage of cyanide encephalopathy isaprimaryeventindemyelination and is not a response tomyelin breakdown. From this experimental evidence it is inferred that oligo-dendroglial activity at the edge of the multiple sclerosis plaque is a primary feature of the disease
process in man.
REFERENCES
Adams, C. W. M. (1959). J. Path.Bact.,77, 648.
(1962) Develop. Med. Child Neurol., 4, 393.
,Davison, A. N.,andGregson,N. A. (1963). J. Neurochem.,
10, 383.
Hess, R.,andPearse, A. G.E.(1961).Exp.Cell.Res.,25,187.
Hortega, P. DelRio (1954). Arch. Histol. (B. Aires), 5, 105
(re-published).
(1956a).Ibid.,6, 132(republished).
Hurst, E. W.(1940).Aust. J.exp.Biol.med.Sci.,18,201.
--(1942). Ibid., 20, 297. (1944).Brain,67, 103. (1952).Amer. J.Med., 12, 547.
Ibrahim, M. Z. M., andAdams,C.W. M.(1963).J.Neurol.Neurosurg.
Psychiat.,26, 101.
Katzman, R.(1961). Neurology(Minneap.),11,27.
Koenig, H. (1960).J.Histochem.Cytochem.,8, 337.
,Bunge, M. B., and Bunge, R. P.(1962).Arch. Neurol.(Chic.),
6, 177.
Levine,S.(1960).J.Neuropath.exp.Neurol., 19,238.
,andStypulkowski, W. (1959). Arch. Path., 67, 306. Lewis,R.C.,andSwank, R.L.(1953).J.Neuropath.exp.Neurol.,
12,57.
Lumsden, C. E.(1950).J.Neurol. Neurosurg.Psychiat., 13, 1.
(1957).lIle Congres InternationaldeNeuropathologie,Bruxelles;
Rapports etDiscussions. "Actamedica Belgica," Brussels,
p.27.
andPomerat, C. M.(1951). Exp.CellRes.,2, 103.
Luse, S. A.(1960).Anat.Rec.,138,461.
Macdonald,M., andSpector,R.G.(1963).Brit.J.exp.Path.,44,11.
Nachlas, M. M., Walker, D. G., and Seligman, A. M. (1958a).
J. biophys.biochem.Cytol., 4,29.
(1958b).Ibid., 4,169.
Osterberg,K.A., andWattenberg,L.W.(1962).Arch.Neural.(Chic.),
7, 211.
Padykula,H.A.,andHerman,E.(1955a).J.Histochem.Cytochem., 3, 161.
(1955b).Ibid.,3, 170. Penfield,W.(1924). Brain, 47, 430.
Rose,C.L.,Harris,P.N.,andChen,K. K.(1954).Proc.Soc.exp.
Biol.(N. Y.), 87,632.
Rubinstein, L.J., andSmith, B.(1962). Nature(Lond.), 193, 895.
,Klatzo,I., andMiquel,J.(1962).J. Neuropath.exp. Neurol.,
21, 116.
Smart,I. (1960).Anat.Rec.,136,279.
-, andLeblond, C.P.(1961).J.comp.Neurol., 116,349.
Smith, B.,andRubinstein,L.J.(1962).J.Path.Bact.,83,572.
Thomas,E., and Pearse,A. G. E.(1961).Z.Zellforsch.Abt.Histochem., 2,266.
vanHouten, W.H.,andFriede,R. L.(1961). Exp. Neurol.,4,402.
Wyndham,R. A.(1941).Aust.J.exp. Biol. med.Sci.,19,243.
Yonezawa, T.,Bornstein,M.B., Peterson, E.R.,andMurray,M.R.
(1962).J.Neuropath.exp.Neurol., 21,479.
Protected by copyright.
on July 4, 2021 by guest.